ArticleScientific reports2022

Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model.

Julie A Zorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.